azacitidine has been researched along with Ductal Carcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arafa, M; Balasubramanian, S; Brown, NJ; Higham, SE; Perunovic, B; Rehman, I | 1 |
| Dai, JL; Liu, H; Sahin, A; Yuan, Y | 1 |
2 other study(ies) available for azacitidine and Ductal Carcinoma
| Article | Year |
|---|---|
Lactate dehydrogenase-B is silenced by promoter methylation in a high frequency of human breast cancers.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Azacitidine; Breast Neoplasms; Carcinoma, Ductal; Case-Control Studies; Cell Line, Tumor; DNA Methylation; Female; Gene Expression Regulation, Neoplastic; Gene Silencing; Glycolysis; Humans; Hypoxia; Isoenzymes; L-Lactate Dehydrogenase; Middle Aged; Neoplasm Proteins; Promoter Regions, Genetic; Sequence Analysis, DNA | 2013 |
Reactivation of SYK expression by inhibition of DNA methylation suppresses breast cancer cell invasiveness.
Topics: Antimetabolites, Antineoplastic; Azacitidine; Breast; Breast Neoplasms; Carcinoma, Ductal; Carcinoma, Intraductal, Noninfiltrating; Cell Proliferation; Decitabine; DNA Methylation; DNA Modification Methylases; Enzyme Precursors; Female; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Intracellular Signaling Peptides and Proteins; Neoplasm Invasiveness; Phenotype; Protein-Tyrosine Kinases; Stilbenes; Syk Kinase | 2005 |